Exocrine Pancreatic Insufficiency

Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market (Therapeutics and Diagnostics (Blood Tests, Endoscopic Ultra-sonography, Magnetic Resonance Imaging (MRI), and CT Scanning) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

  • Rep Id : TMRGL2748
  • Published On : Feb 2018
  • No. of Pages : 154
  • Category : Healthcare

Chapter 1. Preface
1.1. Report Scope and Market Segmentation 
1.2. Research Highlights

Chapter 2. Assumptions and Research Methodology
2.1. Assumptions
2.2. Research Methodology

Chapter 3. Executive Summary : Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market 
3.1. Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Size (US$ Mn) and Distribution by Geography, 2017 and 2025
3.2. Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Snapshot, 2016
3.3. Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market : Opportunity Map

Chapter 4. Market Overview
4.1. Overview
4.2. Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, 2015–2025
4.3. Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Outlook
4.4. U.S. Exocrine Pancreatic Insufficiency Therapeutics Market, Brand Analysis
4.5. Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics Market : Pipeline Analysis
4.6. Exocrine Pancreatic Insufficiency (EPI) Therapeutics Market : U.S. Market Trend & Analysis

Chapter 5. Market Dynamics
5.1. Drivers
       5.1.1. Rise in prevalence of cystic fibrosis and chronic pancreatitis
       5.1.2. Increase in prevalence of diabetes across the world
5.2. Restrains
       5.2.1. Stringent FDA regulations
       5.2.2. Drawbacks of current PERT products
5.3. Opportunity Analysis
5.4. Opportunities
       5.4.1. Pipeline products intended to be substitutes for PERT products
       5.4.2. Emerging economies to offer sustained growth opportunities

Chapter 6. Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Analysis, by Type
6.1. Introduction
6.2. Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Value Share Analysis, by Type
6.3. Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Analysis, by Type 
       6.3.1. Therapeutics
       6.3.2. Diagnostics
                 6.3.2.1. Blood Tests
                 6.3.2.2. Endoscopic Ultra-sonography (EUS)
                 6.3.2.3. Magnetic Resonance Imaging (MRI)
                 6.3.2.4. CT Scanning
6.4. Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Attractiveness Analysis, by Type 
6.5. Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Attractiveness Analysis, by Diagnostics

Chapter 7. Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Analysis, by Region
7.1. Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Snapshot, by Country
7.2. Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Value Share Analysis, by Region
7.3. Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Forecast, by Region
7.4. Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Attractiveness Analysis, by Region
7.5. Key Market Trends By Region

Chapter 8. North America Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Analysis
8.1. Key Findings
8.2. North America Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Overview
8.3. North America Market Value Share Analysis, by Type
8.4. North America Market Forecast, by Type
8.5. Market Analysis, by Country
8.6. Market Value Share Analysis, by Country
8.7. Market Size (US$ Mn) Forecast, by Country, 2017–2025
       8.7.1. U.S.
       8.7.2. Canada
8.8. Market Attractiveness Analysis
8.9. By Type
8.10. By Country

Chapter 9. Europe Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Analysis
9.1. Key Findings
9.2. Europe Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Overview
9.3. Europe Market Value Share Analysis, by Type
9.4. Europe Market Forecast, by Type
9.5. Market Analysis, by Country
9.6. Market Value Share Analysis, by Country
9.7. Market Size (US$ Mn) Forecast, by Country, 2017–2025
       9.7.1. Germany
       9.7.2. France
       9.7.3. U.K.
       9.7.4. Spain
       9.7.5. Italy
       9.7.6. Rest of Europe
9.8. Market Attractiveness Analysis
       9.8.1. By Type
       9.8.2. By Country

Chapter 10. Asia Pacific Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Analysis
10.1. Key Findings
10.2. Asia Pacific Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Overview
10.3. Asia Pacific Market Value Share Analysis, by Type
10.4. Asia Pacific Market Forecast, by Type
10.5. Market Analysis, by Country
10.6. Market Value Share Analysis, by Country
10.7. Market Size (US$ Mn) Forecast, by Country, 2017–2025
       10.7.1. Japan
       10.7.2. China
       10.7.3. India
       10.7.4. Australia & New Zealand
       10.7.5. Rest of Asia Pacific
10.8. Market Attractiveness Analysis
       10.8.1. By Type
       10.8.2. By Country

Chapter 11. Latin America Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Analysis
11.1. Key Findings
11.2. Latin America Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Overview
11.3. Latin America Market Value Share Analysis, by Type
11.4. Latin America Market Forecast, by Type
11.5. Market Analysis, by Country
11.6. Market Value Share Analysis, by Country
11.7. Market Size (US$ Mn) Forecast, by Country, 2017–2025
       11.7.1. Brazil
       11.7.2. Mexico
       11.7.3. Rest of Latin America
11.8. Market Attractiveness Analysis
       11.8.1. By Type
       11.8.2. By Country

Chapter 12. Middle East & Africa Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Analysis
12.1. Key Findings
12.2. Middle East & Africa Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Overview
12.3. Middle East & Africa Market Value Share Analysis, by Type
12.4. Middle East & Africa Market Forecast, by Type
12.5. Market Analysis, by Country
12.6. Market Value Share Analysis, by Country
12.7. Market Size (US$ Mn) Forecast, by Country, 2017–2025
       12.7.1. GCC Countries
       12.7.2. South Africa
       12.7.3. Rest of Middle East & Africa
12.8. Market Attractiveness Analysis
       12.8.1. By Type
       12.8.2. By Country

Chapter 13. Competition Landscape
13.1. Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Share Analysis, by Company, 2016
13.2. Competition Matrix
13.3. Company Profiles
       13.3.1. AbbVie, Inc.
                 13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                 13.3.1.2. Financial Overview
                 13.3.1.3. Product Portfolio
                 13.3.1.4. SWOT Analysis
                 13.3.1.5. Strategic Overview
       13.3.2. Allergan plc
                 13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                 13.3.2.2. Financial Overview
                 13.3.2.3. Product Portfolio
                 13.3.2.4. SWOT Analysis
                 13.3.2.5. Strategic Overview
       13.3.3. Nordmark Arzneimittel GmbH & Co. KG
                 13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                 13.3.3.2. Product Portfolio
                 13.3.3.3. SWOT Analysis
                 13.3.3.4. Strategic Overview
       13.3.4. Digestive Care, Inc.
                 13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                 13.3.4.2. Product Portfolio
                 13.3.4.3. SWOT Analysis
                 13.3.4.4. Strategic Overview
       13.3.5. Janssen Pharmaceuticals, Inc.
                 13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                 13.3.5.2. Financial Overview
                 13.3.5.3. Product Portfolio
                 13.3.5.4. SWOT Analysis
                 13.3.5.5. Strategic Overview
       13.3.6. Cilian AG
                 13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                 13.3.6.2. Product Portfolio
                 13.3.6.3. SWOT Analysis
                 13.3.6.4. Strategic Overview
       13.3.7. Anthera Pharmaceuticals, Inc.
                 13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                 13.3.7.2. Financial Overview
                 13.3.7.3. Product Portfolio
                 13.3.7.4. SWOT Analysis
                 13.3.7.5. Strategic Overview
       13.3.8. AzurRx Biopharma, Inc.
                 13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                 13.3.8.2. Product Portfolio
                 13.3.8.3. SWOT Analysis
                 13.3.8.4. Strategic Overview

List of Tables

Table 01: U.S. EPI Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, By Brands, 2016–2025
Table 02: EPI Therapeutics Brands in the U.S.
Table 03: Global EPI Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, By Pipeline Products, 2019–2025
Table 04: Global EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Type, 2015–2025
Table 05: Global EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Diagnostics, 2015–2025
Table 06: Global EPI Therapeutics & Diagnostics Market Value (US$ Mn) Forecast, by Region, 2015–2025
Table 07: Global EPI Therapeutics Market Value (US$ Mn) Forecast, by Region, 2015–2025
Table 08: Global EPI Diagnostics Market Value (US$ Mn) Forecast, by Region, 2015–2025
Table 09: North America EPI Therapeutics & Diagnostics Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 10: North America EPI Therapeutics Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 11: North America EPI Diagnostics Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 12: North America EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Type, 2015–2025
Table 13: North America EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Diagnostics, 2015–2025
Table 14: Europe EPI Therapeutics & Diagnostics Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 15: Europe EPI Therapeutics Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 16: Europe EPI Diagnostics Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 17: Europe EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Type, 2015–2025
Table 18: Europe EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Diagnostics, 2015–2025
Table 19: Asia Pacific EPI Therapeutics & Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 20: Asia Pacific EPI Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 21: Asia Pacific EPI Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 22: Asia Pacific EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Type, 2015–2025
Table 23: Asia Pacific EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Diagnostics, 2015–2025
Table 24: Latin America EPI Therapeutics & Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 25: Latin America EPI Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 26: Latin America EPI Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 27: Latin America EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Type, 2015–2025
Table 28: Latin America EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Diagnostics, 2015–2025
Table 29: Middle East & Africa EPI Therapeutics & Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 30: Middle East & Africa EPI Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 31: Middle East & Africa EPI Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 32: Middle East & Africa EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Type, 2015–2025
Table 33: Middle East & Africa EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast, by Diagnostics, 2015–2025

 

List of Figures

Figure 01: Acronyms
Figure 02: Global EPI Therapeutics & Diagnostics Market Size (US$ Mn) and Distribution, by Region, 2017 and 2025
Figure 03: Global EPI Therapeutics & Diagnostics Market Snapshot, 2016
Figure 04: Market Opportunity Map, 2016
Figure 05: Global EPI Therapeutics & Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 06: EPI Therapeutics & Diagnostics Market Value Share, by Type (2016)
Figure 07: EPI Therapeutics & Diagnostics Market Value Share, by Diagnostics (2016)
Figure 08: EPI Therapeutics & Diagnostics Market Value Share, by Region (2016)
Figure 09: Total U.S. sales and number of prescriptions of pancreatic enzyme products (PEPs) from 2008-2012 in the United States
Figure 10: Cost per prescription (U.S. Dollars) and number of pancreatic enzyme products (PEPs) marketed in the United States from 2008-12 
Figure 11: Drivers and Restraints Snapshot Figure 151: Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market Share, by Company, 2016
Figure 12: Global EPI Therapeutics & Diagnostics Market Value Share, by Type, 2017 and 2025
Figure 13: Global EPI Therapeutics & Diagnostics Market Attractiveness Analysis, by Type, 2017–2025
Figure 14: Global EPI Therapeutics & Diagnostics Market Value Share, by Diagnostics, 2017 and 2025
Figure 15: Global EPI Therapeutics & Diagnostics Market Attractiveness, by Diagnostics, 2017–2025
Figure 16: Global Exocrine Pancreatic Insufficiency Market Revenue (US$ Mn) Forecast, by Therapeutics, 2015–2025
Figure 17: Global Exocrine Pancreatic Insufficiency Market Revenue (US$ Mn) Forecast, by Diagnostics, 2015–2025
Figure 18: Global Exocrine Pancreatic Insufficiency Diagnostics Market Revenue (US$ Mn) Forecast, by Blood Tests, 2015–2025
Figure 19: Global Exocrine Pancreatic Insufficiency Diagnostics Market Revenue (US$ Mn) Forecast, by Endoscopic Ultra- sonography (EUS), 2015–2025
Figure 20: Global Exocrine Pancreatic Insufficiency Diagnostics Market Revenue (US$ Mn) Forecast, by Magnetic Resonance Imaging (MRI), 2015–2025
Figure 21: Global Exocrine Pancreatic Insufficiency Diagnostics Market Revenue (US$ Mn) Forecast, by CT Scanning, 2015–2025
Figure 22: Global EPI Therapeutics & Diagnostics Market Value Share, by Region, 2017 and 2025
Figure 23: Global EPI Therapeutics & Diagnostics Market Attractiveness, by Region, 2017–2025
Figure 24: North America EPI Therapeutics & Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 25: North America EPI Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 26: North America EPI Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 27: North America EPI Therapeutics & Diagnostics Market Value Share, by Country, 2017 and 2025
Figure 28: North America EPI Therapeutics & Diagnostics Market Attractiveness, by Country, 2017–2025
Figure 29: North America EPI Therapeutics & Diagnostics Market Value Share, by Type, 2017 and 2025
Figure 30: North America EPI Therapeutics & Diagnostics Market Attractiveness, by Type, 2017–2025
Figure 31: Europe EPI Therapeutics & Diagnostics Market Value (US$ Mn), 2015–2025
Figure 32: Europe EPI Therapeutics Market Value (US$ Mn), 2015–2025
Figure 33: Europe EPI Diagnostics Market Value (US$ Mn), 2015–2025
Figure 34: Europe EPI Therapeutics & Diagnostics Market Value Share, by Country, 2017 and 2025
Figure 35: Europe EPI Therapeutics & Diagnostics Market Attractiveness, by Country, 2017–2025
Figure 36: Europe EPI Therapeutics & Diagnostics Market Value Share, by Type, 2017 and 2025
Figure 37: Europe EPI Therapeutics & Diagnostics Market Attractiveness, by Type, 2017–2025
Figure 38: Asia Pacific EPI Therapeutics & Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 39: Asia Pacific EPI Therapeutics & Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Therapeutics, 2015–2025
Figure 40: Asia Pacific EPI Therapeutics & Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Diagnostics, 2015–2025
Figure 41: Asia Pacific EPI Therapeutics & Diagnostics Market Value Share, by Country/Sub-region, 2017 and 2025
Figure 42: Asia Pacific EPI Therapeutics & Diagnostics Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 43: Asia Pacific EPI Therapeutics & Diagnostics Market Value Share, by Type, 2017 and 2025
Figure 44: Asia Pacific EPI Therapeutics & Diagnostics Market Attractiveness, by Type, 2017–2025
Figure 45: Latin America EPI Therapeutics & Diagnostics Market Value (US$ Mn), 2015–2025
Figure 46: Latin America EPI Therapeutics Market Value (US$ Mn), 2015–2025
Figure 47: Latin America EPI Diagnostics Market Value (US$ Mn), 2015–2025
Figure 48: Latin America EPI Therapeutics & Diagnostics Market Value Share, by Country/Sub-region, 2017 and 2025
Figure 49: Latin America EPI Therapeutics & Diagnostics Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 50: Latin America EPI Therapeutics & Diagnostics Market Value Share, by Type, 2017 and 2025
Figure 51: Latin America EPI Therapeutics & Diagnostics Market Attractiveness, by Type, 2017–2025
Figure 52: Middle East & Africa EPI Therapeutics & Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 53: Middle East & Africa EPI Therapeutics & Diagnostics Market Value (US$ Mn), by Therapeutics, 2015–2025
Figure 54: Middle East & Africa EPI Therapeutics & Diagnostics Market Value (US$ Mn), by Diagnostics, 2015–2025
Figure 55: Middle East & Africa EPI Therapeutics & Diagnostics Market Value Share, by Country/Sub-region, 2017 and 2025
Figure 56: Middle East & Africa EPI Therapeutics & Diagnostics Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 57: Middle East & Africa EPI Therapeutics & Diagnostics Market Value Share, by Type, 2017 and 2025
Figure 58: Middle East & Africa EPI Therapeutics & Diagnostics Market Attractiveness, by Type, 2017–2025
Figure 59: Global EPI Therapeutics Market Share, by Company, 2016 
Figure 60: AbbVie, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016
Figure 61: AbbVie, Inc. Breakdown of Net Sales, by Region, 2016 
Figure 62: Janssen Pharmaceuticals, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
Figure 63: Janssen Pharmaceuticals, Inc. Breakdown of Net Sales, by Region, 2016 
Figure 64: Allergan plc Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016
Figure 65: Allergan plc Breakdown of Net Sales, by Segment, 2016 
Figure 66: Anthera Pharmaceuticals, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2016
Figure 67: Anthera Pharmaceuticals, Inc. R&D Expenditure, 2013–2016

 

.